Here's What Makes Pacira BioSciences (PCRX) a Great Buy
Carillon Tower Advisers, an investment management firm, published its “Carillon Scout Small Cap Fund” first quarter 2022 investor letter – a copy of which can be downloaded here.
Pacira Biosciences Inc. (PCRX)
Market is closed
Sector: Pharmaceutical Preparations
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value (x$1000) | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Renaissance Technologies Jim Simons | 1,965,497 | $114,588 | +6% | 0.13% |
| 2. | 81,600,000 | $84,967 | 1.75% | ||
| 3. | Rock Springs Capital Management Kris Jenner, Gordon Bussard, Graham Mcphail | 1,017,500 | $59,320 | +2% | 1.72% |
| 4. | Armistice Capital Steven Boyd | 592,000 | $34,514 | +13% | 0.6% |
| 5. | Paulson & Co John Paulson | 350,000 | $20,405 | -30% | 1% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $36.50 | 2,500 | Officer | 25,237 | 2020-03-11 | Filing | |
| $39.14 | 1,000 | Director | 10,277 | 2019-03-06 | Filing | |
| $38.72 | 700 | Director | 9,277 | 2019-03-06 | Filing | |
| $46.18 | 4,500 | Director | 32,819 | 2018-11-19 | Filing | |
| $51.29 | 4,000 | Director | 28,319 | 2018-11-07 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $55.70 | 476 | Officer | 44,992 | 2022-08-03 | Filing | |
| $55.70 | 308 | Officer | 37,079 | 2022-08-03 | Filing | |
| $56.95 | 533 | Director | 7,179 | 2022-07-11 | Filing | |
| $57.19 | 924 | Officer | 37,387 | 2022-07-05 | Filing | |
| $61.96 | 501 | Officer, Director | 142,251 | 2022-06-08 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value (x$1000) | % Port |
|---|---|---|---|---|
| 1. | 53,927 | $3,143,944 | 0% | |
| 2. | 12,194 | $710,910 | 0% | |
| 3. | 7,111,061 | $414,576 | 0.01% | |
| 4. | 346,000 | $360,564 | 0% | |
| 5. | 4,813,257 | $280,613 | 0% |
News See All
Billionaire John Paulson's Latest Portfolio: Top 10 Stock Picks
In this article, we discuss the top 10 stock picks of billionaire John Paulson’s latest portfolio.
Hedge Funds Are Crazy About Pacira Biosciences Inc (PCRX)
Hedge funds and large money managers usually invest with a focus on the long-term horizon and, therefore, short-lived dips or bumps on the charts usually don't make them change their opinion towards a...
15 Best Stocks to Buy for 2022 According to Analysts
In this article, we discuss the 15 best stocks to buy for 2022 according to analysts.
Hedge Funds Are Coming Back To Pacira Biosciences Inc (PCRX)
Before we spend countless hours researching a company, we like to analyze what insiders, hedge funds and billionaire investors think of the stock first.
10 Best Stocks to Buy According to John Paulson
In this article, we will discuss the 10 best stocks to buy according to John Paulson.
Hedge Fund Sentiment Is Stagnant On Pacira Biosciences Inc (PCRX)
The 800+ hedge funds and famous money managers tracked by Insider Monkey have already compiled and submitted their 13F filings for the first quarter, which unveil their equity positions as of March 31st...
Here is What Hedge Funds Think About Pacira Biosciences Inc (PCRX)
At the end of February we announced the arrival of the first US recession since 2009 and we predicted that the market will decline by at least 20% in (see why hell is coming).
Did Hedge Funds Make The Right Call On Pacira Biosciences Inc (PCRX)?
How do you pick the next stock to invest in? One way would be to spend days of research browsing through thousands of publicly traded companies.
Hedge Funds Souring On Pacira Biosciences Inc (PCRX)
In this article you are going to find out whether hedge funds think Pacira Biosciences Inc (NASDAQ:PCRX) is a good investment right now.
Billionaire Hedge Funds
